甲基巴多索龙通过抑制NLRP3炎症小体活化缓解小鼠急性肝损伤
目的 探究小分子化合物甲基巴多索隆(CDDO-Me)抑制NLRP3炎症小体活化并缓解急性肝损伤的作用机制.方法 体外实验:CDDO-Me预处理小鼠骨髓来源巨噬细胞(BMDM)或人急性单核细胞白血病(THP-1)细胞后,利用多种NLRP3炎症小体活化剂(Nigericin、ATP、MSU、胞内LPS转染)活化NLRP3炎症小体,使用聚脱氧腺苷酸(poly A∶T)活化AIM2炎症小体,通过Western blotting和ELISA检测细胞培养上清中caspase-1和白细胞介素1β(IL-1β)的分泌水平,确定CDDO-Me对NLRP3炎症小体的抑制效果及其特异性.体内实验:将SPF级雄性C5...
Saved in:
Published in | 南方医科大学学报 Vol. 44; no. 9; pp. 1662 - 1669 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | Chinese |
Published |
蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030
2024
蚌埠医科大学第一附属医院检验科,安徽 蚌埠 233004%蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 |
Subjects | |
Online Access | Get full text |
ISSN | 1673-4254 |
DOI | 10.12122/j.issn.1673-4254.2024.09.05 |
Cover
Abstract | 目的 探究小分子化合物甲基巴多索隆(CDDO-Me)抑制NLRP3炎症小体活化并缓解急性肝损伤的作用机制.方法 体外实验:CDDO-Me预处理小鼠骨髓来源巨噬细胞(BMDM)或人急性单核细胞白血病(THP-1)细胞后,利用多种NLRP3炎症小体活化剂(Nigericin、ATP、MSU、胞内LPS转染)活化NLRP3炎症小体,使用聚脱氧腺苷酸(poly A∶T)活化AIM2炎症小体,通过Western blotting和ELISA检测细胞培养上清中caspase-1和白细胞介素1β(IL-1β)的分泌水平,确定CDDO-Me对NLRP3炎症小体的抑制效果及其特异性.体内实验:将SPF级雄性C57BL/6J小鼠随机分为4组,即空白对照组(Control组)、急性肝损伤组(APAP组)、CDDO-Me低剂量治疗组(APAP+CDDO-Me20 mg/kg组)和CDDO-Me高剂量治疗组(APAP+CDDO-Me40 m/kg组),ELISA检测小鼠血清中IL-1β、肿瘤坏死因子α(TNF-α)、谷草转氨酶(AST)、谷丙转氨酶(ALT)的表达水平,HE染色观察肝组织结构变化.结果 CDDO-Me可剂量依赖性的抑制多种激动剂诱导的NLRP3炎症小体活化以及胞内转染LPS诱导非经典NLRP3炎症小体的活化(P<0.05),但对NLRP3炎症小体非依赖的相关炎性因子白细胞介素6(IL-6)、TNF-α的分泌无显著影响(P>0.05).此外,CDDO-Me对AIM2炎症小体的活化无显著影响(P>0.05).动物实验结果表明,相较急性肝损伤组(APAP组),CDDO-Me治疗组(APAP+CDDO-Me20 mg/kg组和APAP+CDDO-Me40 mg/kg组)小鼠血清IL-1β、AST和ALT的表达水平显著降低,肝组织HE染色结果显示CDDO-Me能明显改善ALI小鼠损伤的肝组织结构,减少炎性细胞浸润,且呈剂量依赖性(P<0.05).结论 CDDO-Me能够特异性抑制NLRP3炎症小体活化并缓解APAP诱导的小鼠急性肝损伤. |
---|---|
AbstractList | 目的 探究小分子化合物甲基巴多索隆(CDDO-Me)抑制NLRP3炎症小体活化并缓解急性肝损伤的作用机制.方法 体外实验:CDDO-Me预处理小鼠骨髓来源巨噬细胞(BMDM)或人急性单核细胞白血病(THP-1)细胞后,利用多种NLRP3炎症小体活化剂(Nigericin、ATP、MSU、胞内LPS转染)活化NLRP3炎症小体,使用聚脱氧腺苷酸(poly A∶T)活化AIM2炎症小体,通过Western blotting和ELISA检测细胞培养上清中caspase-1和白细胞介素1β(IL-1β)的分泌水平,确定CDDO-Me对NLRP3炎症小体的抑制效果及其特异性.体内实验:将SPF级雄性C57BL/6J小鼠随机分为4组,即空白对照组(Control组)、急性肝损伤组(APAP组)、CDDO-Me低剂量治疗组(APAP+CDDO-Me20 mg/kg组)和CDDO-Me高剂量治疗组(APAP+CDDO-Me40 m/kg组),ELISA检测小鼠血清中IL-1β、肿瘤坏死因子α(TNF-α)、谷草转氨酶(AST)、谷丙转氨酶(ALT)的表达水平,HE染色观察肝组织结构变化.结果 CDDO-Me可剂量依赖性的抑制多种激动剂诱导的NLRP3炎症小体活化以及胞内转染LPS诱导非经典NLRP3炎症小体的活化(P<0.05),但对NLRP3炎症小体非依赖的相关炎性因子白细胞介素6(IL-6)、TNF-α的分泌无显著影响(P>0.05).此外,CDDO-Me对AIM2炎症小体的活化无显著影响(P>0.05).动物实验结果表明,相较急性肝损伤组(APAP组),CDDO-Me治疗组(APAP+CDDO-Me20 mg/kg组和APAP+CDDO-Me40 mg/kg组)小鼠血清IL-1β、AST和ALT的表达水平显著降低,肝组织HE染色结果显示CDDO-Me能明显改善ALI小鼠损伤的肝组织结构,减少炎性细胞浸润,且呈剂量依赖性(P<0.05).结论 CDDO-Me能够特异性抑制NLRP3炎症小体活化并缓解APAP诱导的小鼠急性肝损伤. |
Abstract_FL | Objective To investigate the inhibitory effect of bardoxolone methyl(CDDO-Me)on activation of NLRP3 inflammasome and its mechanism for alleviating acute liver injury(ALI).Methods Mouse bone marrow-derived macrophages(BMDM)and THP-1 cells were pre-treated with CDDO-Me followed by treatment with Nigericin,ATP,MSU,intracellular LPS transfection for activation of NLRP3 inflammasomes,or poly A:T for activation of AIM2 inflammasomes.The levels of caspase-1 and IL-1β in the cell culture supernatant was determined with Western blotting and ELISA to assess the inhibitory effect of CDDO-Me on NLRP3 inflammasomes and its specificity.In the animal experiment,male C57BL/6J mouse models of acetaminophen-induced ALI were treated with low-dose(20 mg/kg)and high-dose(40 mg/kg)CDDO-Me,and the changes in serum levels of IL-1β,TNF-α,AST and ALT were measured by ELISA and liver tissue pathology was observed using HE staining.Results In mouse BMDM and THP-1 cells,CDDO-Me dose-dependently inhibited the activation of NLRP3 inflammasomes without significantly affecting the secretion of non-inflammasome-related inflammatory factors IL-6 and TNF-α or AIM2 inflammasome activation.In the mouse models of ALI,CDDO-Me treatment at both the low and high doses significantly reduced serum levels of IL-1β,AST and ALT,ameliorated histological changes and reduced inflammatory cell infiltration in the liver tissue,and the effects exhibited a distinct dose dependence.Conclusion CDDO-Me can specifically inhibit the activation of NLRP3 inflammasomes to alleviate acetaminophen-induced ALI in mice. |
Author | 张玮 华梦晴 李明远 |
AuthorAffiliation | 蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030;蚌埠医科大学第一附属医院检验科,安徽 蚌埠 233004%蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 |
AuthorAffiliation_xml | – name: 蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030;蚌埠医科大学第一附属医院检验科,安徽 蚌埠 233004%蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 |
Author_FL | HUA Mengqing LI Mingyuan ZHANG Wei |
Author_FL_xml | – sequence: 1 fullname: LI Mingyuan – sequence: 2 fullname: ZHANG Wei – sequence: 3 fullname: HUA Mengqing |
Author_xml | – sequence: 1 fullname: 李明远 – sequence: 2 fullname: 张玮 – sequence: 3 fullname: 华梦晴 |
BookMark | eNrjYmDJy89LZWBQMTTQMzQyNDLSz9LLLC7O0zM0MzfWNTEyNdEzMjAy0TOw1DMwZWHghAtzMPAWF2cZGBgYWRoZG5qYcjIEPJ-y6en8XU-3b3m6ZNbzLYte7pv5smHWi_3tz7omPu3Y5ucTFGD8vKnv-fT2pxv6n-yd_GzL7qc9057vmfxi-WKgyMs9C541LH3WsPxF09xnvfOf7FnCw8CalphTnMoLpbkZNN1cQ5w9dMsT89IS89Ljs_JLi_KAMvEplVmVKRUVSSCnGlgaGJgZk6IWAFKqZ3s |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.12122/j.issn.1673-4254.2024.09.05 |
DatabaseName | Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitle_FL | Bardoxolone methyl alleviates acute liver injury in mice by inhibiting NLRP3 inflammasome activation |
EndPage | 1669 |
ExternalDocumentID | dyjydxxb202409006 |
GrantInformation_xml | – fundername: 安徽省重点科研平台开放课题基金项目 funderid: (KLICD-2022-D1) |
GroupedDBID | --- 2B. 4A8 92F 92I 93N ABJNI ACGFS ALMA_UNASSIGNED_HOLDINGS CW9 F5P PSX RPM TCJ TGQ U1G U5O |
ID | FETCH-wanfang_journals_dyjydxxb2024090063 |
ISSN | 1673-4254 |
IngestDate | Thu May 29 04:08:05 EDT 2025 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 9 |
Keywords | NLRP3炎症小体 炎症小体相关疾病 甲基巴多索龙 NLRP3 inflammasomes inflammasome-related diseases bardoxolone methyl 急性肝损伤 acute liver injury |
Language | Chinese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-wanfang_journals_dyjydxxb2024090063 |
ParticipantIDs | wanfang_journals_dyjydxxb202409006 |
PublicationCentury | 2000 |
PublicationDate | 2024 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – year: 2024 text: 2024 |
PublicationDecade | 2020 |
PublicationTitle | 南方医科大学学报 |
PublicationTitle_FL | Journal of Southern Medical University |
PublicationYear | 2024 |
Publisher | 蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 蚌埠医科大学第一附属医院检验科,安徽 蚌埠 233004%蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 |
Publisher_xml | – name: 蚌埠医科大学第一附属医院检验科,安徽 蚌埠 233004%蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 – name: 蚌埠医科大学慢性疾病免疫学基础与临床安徽省重点实验室,安徽 蚌埠 233030 |
SSID | ssj0002923145 ssib002263520 ssib051370560 ssib006562552 ssib001186833 |
Score | 4.82383 |
Snippet | 目的 探究小分子化合物甲基巴多索隆(CDDO-Me)抑制NLRP3炎症小体活化并缓解急性肝损伤的作用机制.方法... |
SourceID | wanfang |
SourceType | Aggregation Database |
StartPage | 1662 |
Title | 甲基巴多索龙通过抑制NLRP3炎症小体活化缓解小鼠急性肝损伤 |
URI | https://d.wanfangdata.com.cn/periodical/dyjydxxb202409006 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANJQK4kUUFb8p0jlI2ZqdmWRmTjLZzVJESpEKvZVNmioeVtAW2p5KLxXxA6koFqSilV5FioKu-me6u-2_8L2Xj0ZbtHoJL_PevM_JzHvDJHGcQS3iOGnypNKEIrkip7mu6MQ3FS4Uj6RoSi-mU76j_shNeW3Cm-jrv1o6tTQ7Ew3HC_u-V_I_UYU2iCu-JfsPkS2YQgPAEF-4QoTheqAYs1AxI1nAWegx02CBRSBQLJAIWMmMRRq4tUBjWBAyYxDA8w2A0ixoMK1Y6DNtmaliLw2N_uj1G2MCu2rOdEhyFBECe5fpBgtBbJ0ZgV2BfRBQ1xozPgmsEUozq5gVpV4GUdYlgS6zXg4oJAZZpk4tdbQGRQCxLOfPJKWOygAZyApMJhcVUMgnNQJMt6StrTPrlwAy1Hr5OCM2dTIRAE0AOcXUdkm8XGmFeBuWMTrvDA5O-YODA1neTOG726jIHPwO-qYBQ6YHUR-09iiEhbcUWV9ExiM-pE6KssEv1meDA0RUkQO6NjWWgHS4AIGmAWRDpsmvwD9IGdag4qBxozIREKvU90BsQkTZ3C5oAf15bS-rob32D3EB6Y1bWht9JSowxcvy4pl-vDObJExpJaz62Sqb5Ldm3xUbUidOSzbKGC5kDGN06AvE3m6mUpwfnZq_Mz81NxchkWvok_uHuIJU87ftuir-DEKU81XIr0v1kY_lv1fk915VKDffL8BUjmP5Qz86LxQ77Azmal_5g9L0DmBrutm6VUpXx485R7M6c8Cmk8Zxp2_h9glnrPf8Y2ftS-fzZmd9tbf5duf7q53F1e0fy92HzzoPPtFD31t60nu53PnwdOvbSnfza-fRi157ZXvjHbTstN90F993Fze2l153H69ttddPOpcb4XhtpJJpMZlNW_cn9_hOnHL6W3dbyWlnwAfrdQw1h9uUMq7yyE9iYaTRshmJqenojHPp7_zOHoTonHME4XQz87zTP3NvNrkA6f1MdJFC-BPdYLtk |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%94%B2%E5%9F%BA%E5%B7%B4%E5%A4%9A%E7%B4%A2%E9%BE%99%E9%80%9A%E8%BF%87%E6%8A%91%E5%88%B6NLRP3%E7%82%8E%E7%97%87%E5%B0%8F%E4%BD%93%E6%B4%BB%E5%8C%96%E7%BC%93%E8%A7%A3%E5%B0%8F%E9%BC%A0%E6%80%A5%E6%80%A7%E8%82%9D%E6%8D%9F%E4%BC%A4&rft.jtitle=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5&rft.au=%E6%9D%8E%E6%98%8E%E8%BF%9C&rft.au=%E5%BC%A0%E7%8E%AE&rft.au=%E5%8D%8E%E6%A2%A6%E6%99%B4&rft.date=2024&rft.pub=%E8%9A%8C%E5%9F%A0%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E6%85%A2%E6%80%A7%E7%96%BE%E7%97%85%E5%85%8D%E7%96%AB%E5%AD%A6%E5%9F%BA%E7%A1%80%E4%B8%8E%E4%B8%B4%E5%BA%8A%E5%AE%89%E5%BE%BD%E7%9C%81%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%2C%E5%AE%89%E5%BE%BD+%E8%9A%8C%E5%9F%A0+233030&rft.issn=1673-4254&rft.volume=44&rft.issue=9&rft.spage=1662&rft.epage=1669&rft_id=info:doi/10.12122%2Fj.issn.1673-4254.2024.09.05&rft.externalDocID=dyjydxxb202409006 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fdyjydxxb%2Fdyjydxxb.jpg |